デフォルト表紙
市場調査レポート
商品コード
1387492

トランスフェクション試薬・装置市場レポート:2030年までの動向、予測、競合分析

Transfection Reagent and Equipment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

トランスフェクション試薬・装置市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

トランスフェクション試薬・装置の動向と予測

世界のトランスフェクション試薬・装置市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定19億米ドルに達すると予測されています。この市場の主な促進要因は、世界中で慢性疾患の負担が増加していること、合成遺伝子の需要が高いこと、トランスフェクションの技術的進歩です。世界のトランスフェクション試薬・装置市場の将来は、学術・研究機関や製薬・バイオテクノロジー企業市場でのビジネスチャンスにより有望視されています。

トランスフェクション試薬・装置市場の洞察

Lucintelの予測では、主要企業は試薬ポートフォリオの幅を広げるために多くの製品を発売しているため、試薬が予測期間中に高い成長が見込まれます。

この市場において、製薬・バイオテクノロジー企業は、疾病負担の増加や試薬・機器の世界の採用増加により、最大セグメントであり続けるでしょう。

北米は、ゲノミクスの研究開発への投資の増加、タンパク質治療薬への需要の高まり、同地域の大手企業の存在により、予測期間中も最大セグメントであり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界のトランスフェクション試薬・装置市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界のトランスフェクション試薬・装置市場の動向(2018~2023年)および予測(2024~2030年)
  • 製品別の世界のトランスフェクション試薬・装置市場
    • 試薬
    • 装置
  • 方法別の世界のトランスフェクション試薬・装置市場
    • 物理的方法
    • 生化学的方法
    • ウイルス的方法
  • 用途別の世界のトランスフェクション試薬・装置市場
    • タンパク質生産
    • バイオケミカル研究
    • 治療法の提供
  • 最終用途別の世界のトランスフェクション試薬・装置市場
    • 学術・研究機関
    • 製薬・バイオテクノロジー企業
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のトランスフェクション試薬・装置市場
  • 北米のトランスフェクション試薬・装置市場
  • 欧州のトランスフェクション試薬・装置市場
  • アジア太平洋のトランスフェクション試薬・装置市場
  • その他地域のトランスフェクション試薬・装置市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界のトランスフェクション試薬・装置市場の成長機会
    • 方法別の世界のトランスフェクション試薬・装置市場の成長機会
    • 用途別の世界のトランスフェクション試薬・装置市場の成長機会
    • 最終用途別の世界のトランスフェクション試薬・装置市場の成長機会
    • 地域別の世界のトランスフェクション試薬・装置市場の成長機会
  • 世界のトランスフェクション試薬・装置市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のトランスフェクション試薬・装置市場の能力拡大
    • 世界のトランスフェクション試薬・装置市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche
目次

Transfection Reagent and Equipment Trends and Forecast

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

A more than 150-page report is developed to help in your business decisions.

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents
  • Equipment

Transfection Reagent and Equipment Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Physical Methods
  • Biochemical Methods
  • Viral Methods

Transfection Reagent and Equipment Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Protein Production
  • Biomedical Research
  • Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Academics & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

Transfection Reagent and Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Transfection Reagent and Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transfection reagent and equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Transfection Reagent and Equipment Market Insights

Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Within this market, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.

North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the transfection reagent and equipment market size?

Answer: The global transfection reagent and equipment market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for transfection reagent and equipment market?

Answer: The global transfection reagent and equipment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the transfection reagent and equipment market?

Answer: The major drivers for this market are increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

Q4. What are the major segments for transfection reagent and equipment market?

Answer: The future of the transfection reagent and equipment market looks promising with opportunities in the academic & research institute and parmaceutical & biotechnology company markets.

Q5. Who are the key transfection reagent and equipment market companies?

Answer: Some of the key transfection reagent and equipment companies are as follows:

  • PromoCell
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • Lonza
  • Qiagen N.V.
  • Mirus Bio
  • Promega Corporation
  • F. Hoffmann-La Roche

Q6. Which transfection reagent and equipment market segment will be the largest in future?

Answer: Lucintel forecasts that reagents is expected to witness the higher growth over the forecast period due to huge number of launches by key players so as to broaden their reagents portfolio.

Q7. In transfection reagent and equipment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transfection Reagent and Equipment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transfection Reagent and Equipment Market by Product
    • 3.3.1: Reagents
    • 3.3.2: Equipment
  • 3.4: Global Transfection Reagent and Equipment Market by Method
    • 3.4.1: Physical Methods
    • 3.4.2: Biochemical Methods
    • 3.4.3: Viral Methods
  • 3.5: Global Transfection Reagent and Equipment Market by Application
    • 3.5.1: Protein Production
    • 3.5.2: Biomedical Research
    • 3.5.3: Therapeutic Delivery
  • 3.6: Global Transfection Reagent and Equipment Market by End Use
    • 3.6.1: Academics & Research Institutes
    • 3.6.2: Pharmaceutical & Biotechnology Companies
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transfection Reagent and Equipment Market by Region
  • 4.2: North American Transfection Reagent and Equipment Market
    • 4.2.2: North American Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Transfection Reagent and Equipment Market
    • 4.3.1: European Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.3.2: European Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Transfection Reagent and Equipment Market
    • 4.4.1: APAC Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.4.2: APAC Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Transfection Reagent and Equipment Market
    • 4.5.1: ROW Transfection Reagent and Equipment Market by Product: Reagents and Equipment
    • 4.5.2: ROW Transfection Reagent and Equipment Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
    • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
    • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
    • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
    • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
  • 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PromoCell
  • 7.2: OriGene Technologies
  • 7.3: Thermo Fisher Scientific
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Lonza
  • 7.7: Qiagen N.V.
  • 7.8: Mirus Bio
  • 7.9: Promega Corporation
  • 7.10: F. Hoffmann-La Roche